A case report of granulocyte colony-stimulating factor-producing hepatocellular carcinoma that recurred after long-term complete response

被引:0
作者
Takako Nomura
Asahiro Morishita
Joji Tani
Kei Takuma
Mai Nakahara
Kyoko Oura
Tomoko Tadokoro
Kiyoyuki Kobayashi
Koji Fujita
Shima Mimura
Hideki Kobara
Kunihiko Tsutsui
Takayuki Sanomura
Yoshihiro Nishiyama
Emi Ibuki
Reiji Haba
Teppei Sakamoto
Hirohito Yoneyama
Takashi Himoto
Tsutomu Masaki
机构
[1] Kagawa University,Department of Gastroenterology and Neurology, Faculty of Medicine
[2] Kagawa University,Department of Radiology, Faculty of Medicine
[3] Kagawa University Hospital,Department of Diagnostic Pathology
[4] Yashima General Hospital,Department of Internal Medicine
[5] Saint Martin’s Hospital,Department of Gastroenterology
[6] Kagawa Prefectural University of Health Sciences,Department of Clinical Examination, Faculty of Health Sciences
来源
Clinical Journal of Gastroenterology | 2021年 / 14卷
关键词
Hepatocellular carcinoma; Granulocyte colony-stimulating factor; Leukocytosis;
D O I
暂无
中图分类号
学科分类号
摘要
The granulocyte colony-stimulating factor (G-CSF) is a glycoprotein that stimulates cell proliferation and differentiation of precursor cells in the bone marrow. Several cases of G-CSF-producing malignant tumors in various organs have been reported, but there are only nine cases of G-CSF-producing hepatocellular carcinoma (HCC) reported in the English literature. G-CSF-producing tumors grow rapidly and have a high probability of distant metastases; thus, they generally have a poor prognosis. Given that the mechanism of the carcinogenesis of G-CSF-producing HCC remains unclear, an efficient treatment strategy also remains to be elucidated. We report herein a case of G-CSF-producing HCC accompanied by leukocytosis and high serum G-CSF concentrations in the disease progression stage after long-term complete response. We also reviewed previous reports to investigate the clinical behaviors of G-CSF-producing HCC, including our case. Clinicians should consider G-CSF-producing HCC in patients with a hepatic mass and drastic leukocytosis, without any evidence of infection and blood disorders. Early diagnosis and prompt therapy, including radical resection, may provide a more favorable prognosis.
引用
收藏
页码:204 / 211
页数:7
相关论文
共 70 条
[1]  
Robinson WA(1974)Granulocytosis in neoplasia Ann N Y Acad Sci 230 212-218
[2]  
Lieschke GJ(1992)Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1) N Engl J Med 327 28-35
[3]  
Burgess AW(1977)Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue Blood 49 845-852
[4]  
Asano S(1992)Granulocyte colony-stimulating factor-producing large cell undifferentiated carcinoma of the lung Intern Med 31 277-280
[5]  
Urabe A(1995)Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor Cancer Res 55 3438-3443
[6]  
Okabe T(2005)Granulocyte-colony stimulating factor-producing gallbladder cancer without recurrence more than 2 years after resection: report of a case Surg Today 35 590-593
[7]  
Shijubo N(2008)Anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor: a case report J Med Case Rep 2 391-160
[8]  
Inoue Y(1995)Anaplastic thyroid carcinoma producing the granulocyte colony stimulating factor (G-CSF): report of a case Surg Today 25 158-387
[9]  
Hirasawa M(2000)A case of cervical cancer with aggressive tumor growth: possible autocrine growth stimulation by G-CSF and Il-6 Gynecol Oncol 78 383-550
[10]  
Tachibana M(2010)Intra-arterial therapy with cisplatin suspension in lipiodol and 5-fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis Aliment Pharmacol Ther 32 543-644